These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11331346)

  • 1. Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Costa SD; Kaufmann M
    J Clin Oncol; 2001 May; 19(9):2580; author reply 2580-2. PubMed ID: 11331346
    [No Abstract]   [Full Text] [Related]  

  • 2. Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Panasci LC
    J Clin Oncol; 2001 May; 19(9):2578; author reply 2580-2. PubMed ID: 11331341
    [No Abstract]   [Full Text] [Related]  

  • 3. Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Bagley CM; Rowbotham RK
    J Clin Oncol; 2001 May; 19(9):2578-9; author reply 2580-2. PubMed ID: 11331342
    [No Abstract]   [Full Text] [Related]  

  • 4. Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Tonkin K
    J Clin Oncol; 2001 May; 19(9):2579-80; author reply 2580-2. PubMed ID: 11331344
    [No Abstract]   [Full Text] [Related]  

  • 5. Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?
    Copur MS; Ledakis P; Bolton M; Norvell M; Muhvic J
    J Clin Oncol; 2001 May; 19(9):2578; author reply 2580-2. PubMed ID: 11331343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
    Bergmann L
    Strahlenther Onkol; 2001 May; 177(5):273-4. PubMed ID: 11398617
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on "Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results" by J.-M. Nabholtz et al.
    Mouridsen HT; Chaudri-Ross HA
    Eur J Cancer; 2004 May; 40(7):1095-6; author reply 1097. PubMed ID: 15093587
    [No Abstract]   [Full Text] [Related]  

  • 8. Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.
    Thürlimann B; Hess D; Köberle D; Senn I; Ballabeni P; Pagani O; Perey L; Aebi S; Rochlitz C; Goldhirsch A
    Breast Cancer Res Treat; 2004 Jun; 85(3):247-54. PubMed ID: 15111763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women.
    Vergote I; Bonneterre J; Thürlimann B; Robertson J; Krzakowski M; Mauriac L; Koralewski L; Webster A; Steinberg M; von Euler M
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S84-5. PubMed ID: 11056332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues.
    Winquist E; Bramwell V; Vandenberg T
    J Clin Oncol; 2002 Sep; 20(17):3748-9; author reply 3749-50. PubMed ID: 12202679
    [No Abstract]   [Full Text] [Related]  

  • 11. Superior efficacy of letrozole versus tamoxifen as first-line therapy.
    Buzdar AU
    J Clin Oncol; 2002 Feb; 20(3):876-8. PubMed ID: 11821477
    [No Abstract]   [Full Text] [Related]  

  • 12. Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.
    Milla-Santos A; Milla L; Portella J; Rallo L; Pons M; Rodes E; Casanovas J; Puig-Gali M
    Am J Clin Oncol; 2003 Jun; 26(3):317-22. PubMed ID: 12796608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World's largest breast cancer treatment trial supports anastrozole use.
    Oncology (Williston Park); 2002 Jan; 16(1):63. PubMed ID: 11831610
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.
    Nabholtz JM
    Oncology; 2006; 70(1):1-12. PubMed ID: 16439860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole.
    Valenzano Menada M; Costantini S; Moioli M; Bogliolo S; Papadia A; Ferrero S; Dugnani MC
    Breast; 2008 Dec; 17(6):631-6. PubMed ID: 18606545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
    Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
    J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer.
    Prescrire Int; 2001 Jun; 10(53):76-7. PubMed ID: 11718168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
    Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
    [No Abstract]   [Full Text] [Related]  

  • 19. Focus on anastrozole and breast cancer.
    Mokbel K
    Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.
    Dowsett M; Ebbs SR; Dixon JM; Skene A; Griffith C; Boeddinghaus I; Salter J; Detre S; Hills M; Ashley S; Francis S; Walsh G; Smith IE
    J Clin Oncol; 2005 Apr; 23(11):2477-92. PubMed ID: 15767642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.